Athanasios Karapetsas is a Senior Research Scientist at AstraZeneca, specializing in Biochemistry, Molecular Biology, Immunology, and Cancer Research. They hold a PhD in Molecular Biology and an MSc in Clinical Pharmacology and Therapeutics and have contributed significantly to peer-reviewed journals. Previously, Athanasios worked in various research roles, including postdoctoral positions focused on bee-based natural products and probiotic functional foods, as well as at the MRC Protein Phosphorylation and Ubiquitylation Unit, where they investigated LRRK1's activation mechanisms. Athanasios has a strong interest in uncovering molecular mechanisms of diseases to improve patient outcomes.
Location
Cambridge, United Kingdom